UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) September 3, 1999
GLOBAL MED TECHNOLOGIES, INC.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Colorado 0-22083 84-1116894
---------------------------------------------------------------------
(State or other jurisdiction (Commission File No.) (I.R.S. Employer
of incorporation) Identification No.)
12600 West Colfax, Suite C-420, Lakewood, CO 80215
------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(303) 238-2000
--------------------------------------------------
(Registrant's telephone number, including area code)
1
<PAGE>
Item 4. Changes In Registrant's Independent Accountants
On September 3, 1999, KPMG LLP was dismissed as the independent accountants for
Global Med Technologies, Inc. (the "Company"). KPMG LLP acted as the independent
accountants for the Company for the year ended December 31, 1998. KPMG LLP was
appointed on October 2, 1998 as independent accountants for the Company as
reported in the Current Report on Form 8-K dated October 5, 1998. For the year
ended December 31, 1997, the independent accountants for the Company were Ernst
& Young LLP. Ernst & Young LLP declined to stand for re-election for the year
ended December 31, 1998, as reported in the Current Report on Form 8-K dated
June 19, 1998, as filed on June 25, 1998.
Neither of the reports on the Company's financial statements for the two years
in the period ended December 31, 1998 contained an adverse opinion or disclaimer
of opinion, and neither was modified as to uncertainty, audit scope or
accounting principles.
The decision to change accountants was approved by the Company's Board of
Directors.
During the Company's two most recent fiscal years and subsequent interim period
up to the date of the change in independent accountants, there were no
disagreements with the independent accountants on any matter of accounting
principle or practices, financial statement disclosure, or auditing scope or
procedure, which disagreement(s), if any, not resolved to the satisfaction of
the independent accountants, would have caused the independent accountants to
make a reference to the subject matter of the disagreement(s) in connection with
their reports.
Item 7. Financial Statements and Exhibits.
Exhibit 16 Letter from KPMG LLP
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: September 3, 1999 Global Med Technologies, Inc.
By: /s/ Michael I. Ruxin
--------------------------------
Michael I. Ruxin,
Chief Executive Officer
2
Securities and Exchange Commission
Washington, D.C. 20549
September 3, 1999
Ladies and Gentlemen:
We were previously principal accountants for Global Med Technologies, Inc. (the
Company) and, under the date of April 9, 1999, we reported on the financial
statements of Global Med Technologies, Inc. as of and for the year ended
December 31, 1998. On September 3, 1999, our appointment as principal
accountants was terminated. We have read Global Med Technology, Inc.'s
statements included under Item 4 of its Form 8-K dated September 3, 1999, and we
agree with such statements, except that we are not in a position to agree or
disagree with Global Med Technologies, Inc.'s statements that the change was
approved by the Company's board of directors.
Very truly yours,
/s/ KPMG LLP
KPMG LLP
